(Total Views: 435)
Posted On: 09/19/2024 1:30:37 PM
Post# of 148863
New MS injectible therapy from Roche, FDA approved (mechanism is what's new, drug isn't)
"Ocrevus is a monoclonal antibody designed to target CD20-positive B cells, a specific type of immune cell thought to be a key contributor to nerve cell damage."
https://www.emergencyemail.org/newsemergency/...1&z=58
24 side effects pop up immediately on google...
"Ocrevus is a monoclonal antibody designed to target CD20-positive B cells, a specific type of immune cell thought to be a key contributor to nerve cell damage."
https://www.emergencyemail.org/newsemergency/...1&z=58
24 side effects pop up immediately on google...
(1)
(0)Scroll down for more posts ▼
